Efficacy and Safety of Fecal Microbiota Transplantation for Clearance of Multidrug-Resistant Organisms under Multiple Comorbidities: A Prospective Comparative Trial.

Biomedicines · 2022 · PMC9598999 · PMID 36289668

Europe PMC DOI

hedged sentence

0.0490

closest p · 1.0× alpha

0.0490

boldest claim

The sentences

marginally significantp = 0.049actually significant

The 3-month negative-conversion rate was 52% (14/27) in the FMT group, and 24% (5/21) in the control group, showing a marginally significant difference ( p = 0.049) ( Figure 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.